Content area
Full text
Received May 15, 2017; Accepted Jul 18, 2017
This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1. Introduction
Endoscopic submucosal dissection (ESD) for early gastric cancer (EGC) is commonly performed worldwide as a standard therapy [1]. In the Japanese gastric cancer treatment guidelines, pathological diagnosis is essential to decide ESD indication [2, 3].
Image-enhanced endoscopy is performed for the diagnosis of gastric lesions because of its accuracy and applicability. Magnifying endoscopy with narrow-band imaging (ME-NBI) has a high diagnostic accuracy of superficial gastric lesions compared with white-light imaging endoscopy [4–7], because ME-NBI can also visualize the microstructures and microvessels of the EGCs.
Blue laser imaging (BLI) has recently been developed as a combination of two kinds of laser lights for narrow-band light observation. Magnifying endoscopy with BLI (ME-BLI) is useful for evaluating mucosal surfaces, including surface blood vessels and structure patterns [8–12]. We previously reported the usefulness of ME-BLI for the diagnosis of EGC compared with white-light imaging endoscopy [13]. In another study of ours, we reported that there were differences in 15 of 90 EGCs (16.7%) in microstructure visualization between ME-BLI and ME-NBI. In...